UBS Group’s Unity Biotechnology UBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$58.5K Buy
152,327
+128,026
+527% +$49.2K ﹤0.01% 6370
2025
Q1
$25.3K Buy
24,301
+16,066
+195% +$16.7K ﹤0.01% 6762
2024
Q4
$8.04K Buy
8,235
+7,848
+2,028% +$7.66K ﹤0.01% 7191
2024
Q3
$569 Buy
+387
New +$569 ﹤0.01% 7672
2024
Q2
Sell
-3,494
Closed -$5.73K 8784
2024
Q1
$5.73K Sell
3,494
-5,806
-62% -$9.52K ﹤0.01% 6339
2023
Q4
$17.9K Buy
9,300
+8,940
+2,483% +$17.3K ﹤0.01% 5965
2023
Q3
$864 Buy
360
+350
+3,500% +$840 ﹤0.01% 7094
2023
Q2
$26 Buy
+10
New +$26 ﹤0.01% 7582
2023
Q1
Sell
-8,004
Closed -$21.9K 9030
2022
Q4
$21.9K Buy
8,004
+7,321
+1,072% +$20.1K ﹤0.01% 6383
2022
Q3
$3K Sell
683
-375
-35% -$1.65K ﹤0.01% 8481
2022
Q2
$6K Buy
1,058
+58
+6% +$329 ﹤0.01% 7682
2022
Q1
$11K Buy
1,000
+605
+153% +$6.66K ﹤0.01% 7269
2021
Q4
$6K Sell
395
-298
-43% -$4.53K ﹤0.01% 8177
2021
Q3
$22K Buy
693
+568
+454% +$18K ﹤0.01% 5937
2021
Q2
$6K Sell
125
-288
-70% -$13.8K ﹤0.01% 7363
2021
Q1
$25K Buy
413
+190
+85% +$11.5K ﹤0.01% 6162
2020
Q4
$12K Sell
223
-324
-59% -$17.4K ﹤0.01% 6336
2020
Q3
$19K Buy
547
+52
+11% +$1.81K ﹤0.01% 5484
2020
Q2
$43K Sell
495
-801
-62% -$69.6K ﹤0.01% 5151
2020
Q1
$75K Sell
1,296
-1,910
-60% -$111K ﹤0.01% 4652
2019
Q4
$231K Buy
3,206
+969
+43% +$69.8K ﹤0.01% 4511
2019
Q3
$136K Sell
2,237
-1,233
-36% -$75K ﹤0.01% 4650
2019
Q2
$329K Sell
3,470
-170
-5% -$16.1K ﹤0.01% 3803
2019
Q1
$295K Buy
3,640
+201
+6% +$16.3K ﹤0.01% 3646
2018
Q4
$559K Sell
3,439
-151
-4% -$24.5K ﹤0.01% 3426
2018
Q3
$585K Buy
3,590
+2,779
+343% +$453K ﹤0.01% 3552
2018
Q2
$122K Buy
+811
New +$122K ﹤0.01% 4426